By Professor Monica M. Lahra

Journal articles

Ayfan AKS; Macdonald J; Irwin AD; Zowawi HM; Forde BM; Paterson DL; Lahra MM; Whiley DM, 2022, 'Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility', Journal of Antimicrobial Chemotherapy, 77, pp. 2933 - 2936, http://dx.doi.org/10.1093/jac/dkac242

Tickner JA; Lahra MM; Whiley DM, 2022, 'The need for a commercial test using the penA60 allele to identify ceftriaxone-resistant Neisseria gonorrhoeae', Lancet Infectious Diseases, 22, pp. 1271 - 1272, http://dx.doi.org/10.1016/S1473-3099(22)00520-5

Lahra MM; Hogan TR; Armstrong BH, 2022, 'Australian Gonococcal Surveillance Programme Annual Report, 2021', Communicable Diseases Intelligence 2018, 46, http://dx.doi.org/10.33321/cdi.2022.46.52

Lahra MM; Ray S; Hogan TR, 2022, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2022', Communicable Diseases Intelligence 2018, 46, http://dx.doi.org/10.33321/cdi.2022.46.56

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Australian Gonococcal Surveillance Programme, 1 October to 31 December 2021', Communicable Diseases Intelligence 2018, 46, http://dx.doi.org/10.33321/cdi.2022.46.43

Lahra MM; George CR; Hogan TR, 2022, 'Australian Meningococcal Surveillance Programme Annual Report, 2021', Communicable Diseases Intelligence 2018, 46, http://dx.doi.org/10.33321/cdi.2022.46.46

Lahra MM; Ray S; Hogan TR, 2022, 'Meningococcal Surveillance Australia Reporting period 1 January to 31 March 2022', Communicable Diseases Intelligence 2018, 46, http://dx.doi.org/10.33321/cdi.2022.46.36

George CR; Booy R; Nissen MD; Lahra MM, 2022, 'The decline of invasive meningococcal disease and influenza in the time of COVID-19: the silver linings of the pandemic playbook', Medical Journal of Australia, 216, pp. 504 - 507, http://dx.doi.org/10.5694/mja2.51463

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Meningococcal Surveillance Australia Reporting period 1 October to 31 December 2021', Communicable Diseases Intelligence 2018, 46, http://dx.doi.org/10.33321/cdi.2022.46.21

Hui BB; Padeniya TN; Rebuli N; Gray RT; Wood JG; Donovan B; Duan Q; Guy R; Hocking JS; Lahra MM; Lewis DA; Whiley DM; Regan DG; Seib KL, 2022, 'A Gonococcal Vaccine Has the Potential to Rapidly Reduce the Incidence of Neisseria gonorrhoeae Infection among Urban Men Who Have Sex with Men', Journal of Infectious Diseases, 225, pp. 983 - 993, http://dx.doi.org/10.1093/infdis/jiab581

Lahra MM; Shoushtari M; Hogan TR, 2022, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2021', Communicable Diseases Intelligence 2018, 46, http://dx.doi.org/10.33321/cdi.2022.46.1

Cabrera-Aguas M; Khoo P; George CRR; Lahra MM; Watson SL, 2022, 'Predisposing factors, microbiological features and outcomes of patients with clinical presumed concomitant microbial and herpes simplex keratitis', Eye Basingstoke, 36, pp. 86 - 94, http://dx.doi.org/10.1038/s41433-021-01440-1

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme 1 April to 30 June 2021', Communicable Diseases Intelligence 2018, 45, http://dx.doi.org/10.33321/cdi.2021.45.68

Lahra MM; Shoushtari M; Hogan T, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2021', Communicable Diseases Intelligence 2018, 45, http://dx.doi.org/10.33321/cdi.2021.45.63

Duan Q; Carmody C; Donovan B; Guy RJ; Hui BB; Kaldor JM; Lahra MM; Law MG; Lewis DA; Maley M; McGregor S; McNulty A; Selvey C; Templeton DJ; Whiley DM; Regan DG; Wood JG, 2021, 'Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in Australia', PLoS Computational Biology, 17, pp. e1009385, http://dx.doi.org/10.1371/journal.pcbi.1009385

Unemo M; Lahra MM; Escher M; Eremin S; Cole MJ; Galarza P; Ndowa F; Martin I; Dillon JAR; Galas M; Ramon-Pardo P; Weinstock H; Wi T, 2021, 'WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017–18: a retrospective observational study', Lancet Microbe, 2, pp. e627 - e636, http://dx.doi.org/10.1016/S2666-5247(21)00171-3

Lahra MM; Hogan TR; Shoushtari M; Armstrong BH, 2021, 'Australian Gonococcal Surveillance Programme Annual Report, 2020', Communicable Diseases Intelligence 2018, 45, http://dx.doi.org/10.33321/cdi.2021.45.58

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme 1 October to 31 December 2020', Communicable Diseases Intelligence 2018, 45, http://dx.doi.org/10.33321/cdi.2021.45.44

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2021', Communicable Diseases Intelligence 2018, 45

Lahra MM; George CRR; Shoushtari M; Hogan TR, 2021, 'Australian Meningococcal Surveillance Programme Annual Report, 2020', Communicable Diseases Intelligence 2018, 45, http://dx.doi.org/10.33321/cdi.2021.45.46

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Communicable Diseases Intelligence', COMMUNICABLE DISEASES INTELLIGENCE, 45, http://dx.doi.org/10.33321/cdi.2021.45.47

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2021', Communicable Diseases Intelligence 2018, 45, http://dx.doi.org/10.33321/cdi.2021.45.45

Lahra MM; Shoushtari M; Hogan TR, 2021, 'Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2020', Communicable Diseases Intelligence 2018, 45, http://dx.doi.org/10.33321/cdi.2021.45.36

Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR, 2021, 'Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18', Journal of Antimicrobial Chemotherapy, 76, pp. 1815 - 1821, http://dx.doi.org/10.1093/jac/dkab099

Lahra MM; Hogan TR; Shoushtari M; Armstrong BH, 2021, 'Australian Gonococcal Surveillance Programme Annual Report, 2020', COMMUNICABLE DISEASES INTELLIGENCE, 45, http://dx.doi.org/10.33321/cdi.2021.45.24

Lahra MM; Hogan TR; Shoushtari M; Armstrong BH, 2021, 'Australian Gonococcal Surveillance Programme Annual Report, 2020', Communicable Diseases Intelligence 2018, 45, http://dx.doi.org/10.33321/cdi.2021.45.24

Armstrong BH; Limnios A; Lewis DA; Hogan T; Kundu R; Ray S; Shoushtari M; El Nasser J; Driscoll T; Lahra MM, 2021, 'Is gentamicin a viable therapeutic option for treating resistant Neisseria gonorrhoeae in New South Wales?', Communicable Diseases Intelligence 2018, 45, http://dx.doi.org/10.33321/cdi.2021.45.12

Trembizki E; Jennison AV; Buckley C; Bright A; Holds J; Ward A; Pitt J; Pendle S; Baird R; Freeman K; Robson J; Mhango L; Lowry K; Lahra M; Whiley D, 2021, 'Enhanced molecular surveillance in response to the detection of extensively resistant gonorrhoea in Australia', Journal of Antimicrobial Chemotherapy, 76, pp. 270 - 271, http://dx.doi.org/10.1093/JAC/DKAA402

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme 1 July to 30 September 2020', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.96

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Meningococcal Surveillance Australia Reporting period 1 July to 30 September 2020', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.95

Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR, 2020, 'Laboratory-based surveillance of clostridium difficile infection in australian health care and community settings, 2013 to 2018', Journal of Clinical Microbiology, 58, http://dx.doi.org/10.1128/JCM.01552-20

Cabrera-Aguas M; Khoo P; Lahra MM; Watson SL, 2020, 'Travel associated microbial keratitis: is resistance a risk?', Travel Medicine and Infectious Disease, 38, http://dx.doi.org/10.1016/j.tmaid.2020.101903

Watson SL; Gatus BJ; Cabrera-Aguas M; Armstrong BH; George CR; Khoo P; Lahra MM, 2020, 'Bacterial Ocular Surveillance System (BOSS) Sydney, Australia 2017-2018', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.86

Lahra MM; Shoushtari M; Ray S, 2020, 'Meningococcal Surveillance Australia Reporting period 1 April to 30 June 2020', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.81

Hepschke JL; Ung L; Cabrera-Aguas M; Ross C; Kumar N; Lahra MM; Watson S, 2020, 'Pediatric Microbial Keratitis: Experience From Tertiary Referral Centers in New South Wales, Australia', Pediatric Infectious Disease Journal, 39, pp. 883 - 888, http://dx.doi.org/10.1097/INF.0000000000002723

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme: 1 April to 30 June 2020', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.74

Lahra MM; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme: 1 July to 30 September 2019', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.73

Ferreyra C; Osborn J; Moussy F; Alirol E; Lahra M; Whiley D; Shafer W; Unemo M; Klausner J; Cirino CK; Wi T, 2020, 'Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus', Plos One, 15, http://dx.doi.org/10.1371/journal.pone.0237424

Lahra MM; Hogan TR, 2020, 'Australian Meningococcal Surveillance Programme annual report, 2019', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.62

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Meningococcal Surveillance Australia Reporting period 1 January to 31 March 2020', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.65

George CRR; Kundu RL; Whiley DM; Lahra MM, 2020, 'Are sex norms the norm in gonococcal surveillance?', Lancet Microbe, 1, pp. e143 - e144, http://dx.doi.org/10.1016/S2666-5247(20)30087-2

Khoo P; Cabrera-Aguas MP; Nguyen V; Lahra MM; Watson SL, 2020, 'Microbial keratitis in Sydney, Australia: risk factors, patient outcomes, and seasonal variation', Graefe S Archive for Clinical and Experimental Ophthalmology, 258, pp. 1745 - 1755, http://dx.doi.org/10.1007/s00417-020-04681-0

Lahra MM; Shoushtari M; George CRR; Armstrong BH; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme Annual Report, 2019', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.58

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2020', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.61

Lahra MM; Hogan TR, 2020, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2019', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.47

Lahra MM; Hogan TR, 2020, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2019', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.50

Lahra MM; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2019', Communicable diseases intelligence (2018), 44, http://dx.doi.org/10.33321/cdi.2020.44.37

Lahra MM; Enriquez RP; Hogan TP, 2020, 'Australian Meningococcal Surveillance Programme annual report, 2018', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.10

Cabrera-Aguas M; Khoo P; George CRR; Lahra MM; Watson SL, 2020, 'Antimicrobial resistance trends in bacterial keratitis over 5 years in Sydney, Australia', Clinical and Experimental Ophthalmology, 48, pp. 183 - 191, http://dx.doi.org/10.1111/ceo.13672

Fifer H; Hughes G; Whiley D; Lahra MM, 2020, 'Lessons learnt from ceftriaxone-resistant gonorrhoea in the UK and Australia', Lancet Infectious Diseases, 20, pp. 276 - 278, http://dx.doi.org/10.1016/S1473-3099(20)30055-4

Back to profile page